Search

Platelet Rich Plasma: How Does It Work, and Does It Work? What Is the Evidence?

Continuing Medical Education

platelet rich plasma

Eligible for online CME Credit

Member LOGIN for full article and CME Test


By Stuart M. Caplen, MD


In an effort to improve healing, injection of platelet rich plasma (PRP) is currently being utilized for many different medical conditions. In 2018 it was estimated that the global PRP market was expected to grow to between $380 million and $4.5 billion in the next ten years. The cost of a single treatment, which is not covered by most insurance, was estimated at approximately $500–$2,500, with patients often needing multiple treatments.[1] This article will discuss how PRP works and look at the current evidence as to whether it does improve healing for assorted conditions.


What Is Platelet Rich Plasma?

Platelet rich plasma is derived from blood drawn from an individual, which is then used in treating that same individual. The blood is specially processed to produce plasma, containing a large number of platelets. The theory behind PRP therapy is that an injection or deposition of concentrated platelets at sites of injury may aid tissue repair by releasing biologically active factors.[2]


Platelets contain seven growth factors required for wound healing. They also contain the proteins fibrin, fibronectin, and vitronectin that are used for cell adhesion in bone, connective tissue, and epithelial tissue. Platelet growth factors are stored in platelet alpha granules, and are released after an injury. These growth factors are secreted through the platelet cell membrane after the initiation of the blood clotting cascade. The growth factors next bind to the external surface of cells in the area where they were deposited or injected. The platelets continue to synthesize and secrete more growth factors for the approximately seven days of their life span.[3] PRP theoretically can stimulate the supraphysiological release of growth factors to jump-start healing in chronic injuries, and accelerate the acute injury repair process.[2] After the platelets die, macrophages take over wound healing regulation by secreting their own growth factors.

There are many different methods of preparing PRP. Variations in PRP include . . .



What are the variations in PRP?


How is PRP prepared?


What is Buffy Coat PRP?


What are the Uses of PRP?


Which specialities are using PRP?


Which dermatologic condition has not been associated with PRP treatment- acne scars, wrinkles and sagging, or hair loss?


For the answers, read the Conclusion of Platelet Rich Plasma

 

FibonacciMD APP Members: Take the CME test


Not an APP member? Membership info.


Non-members can download the Platelet Rich Plasma PDF for $1.00 on the APP

#CME #FibonacciCME

 

ABOUT THE AUTHOR

Stuart M. Caplen, MD, FACEP, MSM

Dr. Caplen is a retired emergency medicine physician and former emergency department medical director, who also has a Master of Science in Management degree, and green belt certification in Lean/Six Sigma.



References

[1] Jones IA, Togashi RC, Thomas Vangsness C Jr. The Economics and Regulation of PRP in the Evolving Field of Orthopedic Biologics. Curr Rev Musculoskelet Med. 2018;11(4):558-565. Retrieved from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220002/

[2] Everts P, Onishi K, Jayaram P, Lana JF, Mautner K. Platelet-Rich Plasma: New Performance Understandings and Therapeutic Considerations in 2020. Int J Mol Sci. 2020;21(20):7794. Published 2020 Oct 21. Retrieved from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7589810/

[3] Marx RE. Platelet-Rich Plasma: Evidence to Support Its Use. J Oral Maxillofac Surg 62:489-496, 2004. Retrieved from: http://www.drkoprp.com/pdfs/prp/PRPbyDr.Marx.pdf

[4] Jones IA, Togashi RC, Thomas Vangsness C Jr. The Economics and Regulation of PRP in the Evolving Field of Orthopedic Biologics. Curr Rev Musculoskelet Med. 2018;11(4):558-565. Retrieved from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220002/

[5] Muthuprabakaran K. et al. A cross-sectional analysis of the effects of various centrifugation speeds and inclusion of the buffy coat in platelet-rich plasma preparation. Indian Journal of Dermatology, Venereology and Leprology. 87 (6); 792-799. October 2021. Retrieved from: https://ijdvl.com/a-cross-sectional-analysis-of-the-effects-of-various-centrifugation-speeds-and-inclusion-of-the-buffy-coat-in-platelet-rich-plasma-preparation/#ref6\

[6] Jiang G et al. Comparison of leukocyte-rich platelet-rich plasma and leukocyte-poor platelet-rich plasma on achilles tendinopathy at an early stage in a rabbit model. Am J Sports Med. 2020;48:1189-99. Retrieved from: https://pubmed.ncbi.nlm.nih.gov/32134682/

[6A] Xu Z et al. Comparative evaluation of leukocyte- and platelet-rich plasma and pure platelet-rich plasma for cartilage regeneration. Sci Rep 7, 43301 (2017). https://doi.org/10.1038/srep43301

[7] Giusti I et al. Leukocyte depletion does not affect the in vitro healing ability of platelet rich plasma. Exp Ther Med. 2018;15:4029-38. Retrieved from: https://ijdvl.com/a-cross-sectional-analysis-of-the-effects-of-various-centrifugation-speeds-and-inclusion-of-the-buffy-coat-in-platelet-rich-plasma-preparation/#ref27

[8] Dragoo JL et al. Comparison of the acute inflammatory response of two commercial platelet-rich plasma systems in healthy rabbit tendons. Am J Sports Med. 2012 Jun;40(6):1274-81. Retrieved from: https://pubmed.ncbi.nlm.nih.gov/22495144/

[9] Kim J-H et al. Adverse Reactions and Clinical Outcomes for Leukocyte-Poor Versus Leukocyte-Rich Platelet-Rich Plasma in Knee Osteoarthritis: A Systematic Review and Meta-analysis. Orthopaedic Journal of Sports Medicine. June 2021. Retrieved from: 10.1177/23259671211011948

[10] PRP Labs Editorial Team. How to Activate Platelet Rich Plasma (PRP). PRP Labs. May 6th, 2018. Retrieved from: https://prplabs.com/blog/how-to-activate-platelet-rich-plasma-prp/

[11]Scherer SS et al. Non-activated versus thrombin-activated platelets on wound healing and fibroblast-to-myofibroblast differentiation in vivo and in vitro. Plast Reconstr Surg. 2012;129:46e–54e. Retrieved from: https://pubmed.ncbi.nlm.nih.gov/22186584/

[12] Gentile P et al. Evaluation of Not-Activated and Activated PRP in Hair Loss Treatment: Role of Growth Factor and Cytokine Concentrations Obtained by Different Collection Systems. Int J Mol Sci. 2017;18(2):408. Published 2017 Feb 14. Retrieved from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5343942/

[13] Queiroz da Silva L et al. Platelet Activation Is Not Crucial for Platelet-Rich Plasma (PRP), When Used As Autologous Therapeutic Product, and Could be Lyophilized without Any Growth Factor Loss. Blood (2016) 128 (22). Retrieved from: https://ashpublications.org/blood/article/128/22/2639/98543/Platelet-Activation-Is-Not-Crucial-for-Platelet

[14] Cavallo C et al. “Platelet-Rich Plasma: The Choice of Activation Method Affects the Release of Bioactive Molecules,” BioMed Research International, vol. 2016, Article ID 6591717, 7 pages, 2016. Retrieved from: https://www.hindawi.com/journals/bmri/2016/6591717/

[15] Ranly DM et al. Platelet-derived growth factor inhibits demineralized bone matrix-induced intramuscular cartilage and bone formation. A study of immunocompromised mice. J Bone Joint Surg Am. 2005;87(9):2052-64. Retrieved from: https://pubmed.ncbi.nlm.nih.gov/16140821/

[16] Dhurat R, Sukesh M. Principles and Methods of Preparation of Platelet-Rich Plasma: A Review and Author's Perspective. J Cutan Aesthet Surg. 2014;7(4):189-197. Retrieved from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4338460/#ref15

[17] Dório, M et al. Efficacy of platelet-rich plasma and plasma for symptomatic treatment of knee osteoarthritis: a double-blinded placebo-controlled randomized clinical trial. BMC Musculoskelet Disord 22, 822 (2021). Retrieved from: https://bmcmusculoskeletdisord.biomedcentral.com/track/pdf/10.1186/s12891-021-04706-7.pdf

[18] Platelet-Rich Plasma for Wound Care in the Medicare Population. Agency for Healthcare Research and Quality U.S. Department of Health and Human Services. Technology Assessment Project ID: MYOE59 September 17, 2020. Retrieved from: https://www.ahrq.gov/sites/default/files/wysiwyg/research/findings/ta/prp/prp-wound-care.pdf

[19] Carter MJ, Fylling CP, Parnell LK. Use of platelet rich plasma gel on wound healing: a systematic review and meta-analysis. Eplasty. 2011;11:e38.Retrieved from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3174862/

[20] Martinez‐Zapata MJ et al. Autologous platelet‐rich plasma for treating chronic wounds. Cochrane Database of Systematic Reviews. 25 May 2016. Retrieved from: https://pubmed.ncbi.nlm.nih.gov/27223580/

[21] Moraes VY et al. Platelet-rich therapies for musculoskeletal soft tissue injuries. Cochrane Database Syst Rev. 2013 Dec 23;(12):CD010071. Update in: Cochrane Database Syst Rev. 2014;(4):CD010071. PMID: 24363098. Retrieved from: https://pubmed.ncbi.nlm.nih.gov/24363098/

[22] Tang S et al. Platelet-Rich Plasma Vs Autologous Blood Vs Corticosteroid Injections in the Treatment of Lateral Epicondylitis: A Systematic Review, Pairwise and Network Meta-Analysis of Randomized Controlled Trials. PM R. 2020;12(4):397-409. Retrieved from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187193/

[23] Karjalainen TV et al. Autologous blood and platelet-rich plasma injection therapy for lateral elbow pain. Cochrane Database of Systematic Reviews 2021, Issue 9. Art. No.: CD010951. Retrieved from: https://www.cochrane.org/CD010951/MUSKEL_autologous-blood-or-prp-injection-lateral-elbow-pain

[24] Niemiec P et al. Why PRP works only on certain patients with tennis elbow? Is PDGFB gene a key for PRP therapy effectiveness? A prospective cohort study. BMC Musculoskelet Disord. 2021;22(1):710. Published 2021 Aug 18. Retrieved from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8375168/

[25] Yang WY et al. Platelet-rich plasma as a treatment for plantar fasciitis: A meta-analysis of randomized controlled trials. Medicine (Baltimore). 2017;96(44):e8475. Retrieved from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5682822/

[26] Yu, T et al. Outcomes of platelet-rich plasma for plantar fasciopathy: a best-evidence synthesis. J Orthop Surg Res 15, 432 (2020). https://doi.org/10.1186/s13018-020-01783-7

[27] Dório, M et al. Efficacy of platelet-rich plasma and plasma for symptomatic treatment of knee osteoarthritis: a double-blinded placebo-controlled randomized clinical trial. BMC Musculoskelet Disord 22, 822 (2021). Retrieved from: https://bmcmusculoskeletdisord.biomedcentral.com/track/pdf/10.1186/s12891-021-04706-7.pdf

[28] Filardo G et al. (2012b) Platelet-rich plasma intra-articular knee injections show no superiority versus viscosupplementation: a randomized controlled trial. Am J Sports Med 43:1575–1582. https://pubmed.ncbi.nlm.nih.gov/25952818/

[29] Cole BJ et al. Hyaluronic Acid Versus Platelet-Rich Plasma: A Prospective, Double-Blind Randomized Controlled Trial Comparing Clinical Outcomes and Effects on Intra-articular Biology for the Treatment of Knee Osteoarthritis. Am J Sports Med. 2017 Feb;45(2):339-346. https://pubmed.ncbi.nlm.nih.gov/28146403/

[30] Formica M, Cavagnaro L, Formica C, Mastrogiacomo M, Basso M, Di Martino A. What is the preclinical evidence on platelet rich plasma and intervertebral disc degeneration? Eur Spine J. 2015 Nov;24(11):2377-86. Retrieved from: https://pubmed.ncbi.nlm.nih.gov/26272374/

[31] Mohammed S, Yu J. Platelet-rich plasma injections: an emerging therapy for chronic discogenic low back pain. J Spine Surg. 2018;4(1):115-122. Retrieved from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5911760/#r33

[32] Yetsa A et al. Lumbar Intradiskal Platelet-Rich Plasma (PRP) Injections: A Prospective, Double-Blind, Randomized Controlled Study, PM&R, Volume 8, Issue 1, 2016, Pages 1-10. Retrieved from: https://www.sciencedirect.com/science/article/pii/S1934148215009715?via%3Dihub

[33] Chang MC, Park D. The Effect of Intradiscal Platelet-Rich Plasma Injection for Management of Discogenic Lower Back Pain: A Meta-Analysis. J Pain Res. 2021;14:505-512 https://doi.org/10.2147/JPR.S292335

[34] Xuan Z, Yu W, Dou Y, Wang T. Efficacy of Platelet-rich Plasma for Low Back Pain: A Systematic Review and Meta-analysis. J Neurol Surg A Cent Eur Neurosurg. 2020 Nov;81(6):529-534. Retrieved from: https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0040-1709170

[35] Wu, YT. et al. Six-month efficacy of platelet-rich plasma for carpal tunnel syndrome: A prospective randomized, single-blind controlled trial. Sci Rep 7, 94 (2017). https://doi.org/10.1038/s41598-017-00224-6

[36] Dong C, Sun Y, Qi Y, et al. Effect of Platelet-Rich Plasma Injection on Mild or Moderate Carpal Tunnel Syndrome: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials. Biomed Res Int. 2020;2020:5089378. Published 2020 Nov 14. Retrieved from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683131/

[37] Mao, G., Zhang, G. & Fan, W. Platelet-Rich Plasma for Treating Androgenic Alopecia: A Systematic Review. Aesth Plast Surg 43, 1326–1336 (2019). https://doi.org/10.1007/s00266-019-01391-9

[38] Schoenberg E et al. Platelet-rich plasma for facial rejuvenation: An early examination. Clinics in Dermatology, Volume 38, Issue 2, 2020, Pages 251-253. Retrieved from: https://doi.org/10.1016/j.clindermatol.2019.06.003.

[39] Alser OH, Goutos I. The evidence behind the use of platelet-rich plasma (PRP) in scar management: a literature review. Scars Burn Heal. 2018;4. Published 2018 Nov 18. Retrieved from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6243404/



DISCLAIMER

IMIT takes pride in its work, and the information published on the IMIT Platform is believed to be accurate and reliable. The IMIT Platform is provided strictly for informational purposes, and IMIT recommends that any medical, diagnostic, or other advice be obtained from a medical professional. Read full disclaimer.